Successful Treatment of Refractory IgA‐Mediated Autoimmune Hemolytic Anemia With Bortezomib

ABSTRACT Introduction IgA‐mediated autoimmune hemolytic anemia (AIHA) is a rare condition associated with severe hemolysis and limited therapeutic response. Bortezomib, a proteasome inhibitor, targets plasma cells responsible for autoantibody production. Here, we describe a case of refractory IgA‐me...

Descripció completa

Dades bibliogràfiques

Autors principals:	Silvia Neri, Corien L. Eckhardt, Boukje M. Beuger, Folman Folman, Eva Rettenbacher, Hanke L. Matlung, Taco W. Kuijpers, Josephine M. I. Vos, Robin vanBruggen
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2025-12-01
Col·lecció:	eJHaem
Accés en línia:	https://doi.org/10.1002/jha2.70162
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!